Research and analysis

ACRE advice: application for a trial of genetically modified Salmonella Paratyphi (20/R48/01a)

ACRE's advice on an application from Oxford Vaccine Group to carry out a trial of genetically modified Salmonella Paratyphi.

• From: Advisory Committee on Releases to the Environment
• Published: 7 March 2022

Documents

Advice on an application for deliberate release of a genetically modified organism (GMO) for research and development purposes

PDF, 172 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

These documents are the advice of the Advisory Committee on Releases to the Environment (ACRE) to government on an application from Oxford Vaccine Group to carry out a trial of genetically modified Salmonella Paratyphi.

The committee advised that the risks to human health and the environment from this trial are extremely low.

Published 7 March 2022